Cytokine profile and lymphocyte subsets in type 2 diabetes

Area of Science:

• Immunology
• Endocrinology
• Metabolic Diseases

Background:

• Type 2 diabetes (T2D) is a metabolic disorder characterized by inflammation.
• The specific immune cell profiles and cytokine patterns in T2D pathogenesis remain unclear.
• Understanding immune system involvement is crucial for T2D management.

Purpose of the Study:

• To investigate immune cell subsets and cytokine production in T2D patients.
• To quantify lymphocyte subsets and intracellular cytokine production by T cells in T2D.
• To explore the relationship between immune markers and clinical parameters in T2D.

Main Methods:

• Collected clinical data and blood samples from 22 T2D patients and 20 healthy male controls.
• Assessed lymphocyte subsets (B cells, T cells, NK cells, T regulatory cells) via flow cytometry.
• Quantified intracellular production of IL-4, IL-10, IL-17, TNF-α, and IFN-γ by CD3+ T cells.

Main Results:

• No significant differences in the frequencies of B cells, CD8+ T cells, CD4+ T cells, NK cells, or T regulatory cells between T2D patients and controls.
• Significantly higher numbers of IL-10 and IL-17 producing CD3+ T cells were observed in T2D patients compared to controls (P<0.05).
• Interferon-γ (IFN-γ) producing CD3+ T cell frequency positively correlated with body mass index (r=0.59; P=0.01).

Conclusions:

• Increased circulating IL-10 and IL-17 producing CD3+ T cells are associated with T2D.
• These specific cytokines may play a significant role in the immune pathology of Type 2 Diabetes.
• Further research into these cytokine pathways could reveal novel therapeutic targets for T2D.